Munich - Delayed Quote • EUR Canopy Growth Corp. R (11L.MU) Follow Compare 2.3800 -0.2000 (-7.75%) As of 6:22:02 PM GMT+1. Market Open. All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations New York cannabis sales set for $1.5B surge in 2025 New York’s cannabis market is poised for major growth in 2025, with sales expected to hit $1.5 billion and the number of legal marijuana shops more than doubling. Dan Ahrens, AdvisorShares Pure US Cannabis ETF portfolio manager, joins Market Domination to discuss how current political delays and market volatility have affected cannabis stock. "We keep expecting federal reform, we keep getting promised federal reform, and when we had this past election, these cannabis stocks took yet another hit because the investing public out there really thinks that the Republican Party is bad for cannabis," Ahrens explains. He notes the Democratic Party could have been good for cannabis but that "people in our space feel like we've just been gaslighted for the past four years by Democrats.” Ahrens still suggests 2025 could bring change, with cannabis potentially rescheduled as a Schedule III controlled substance, which would be a big positive for companies. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Josh Lynch Is Canopy Growth (CGC) Among the Best CBD Stocks to Invest In Right Now? We recently published a list of 7 Best CBD Stocks To Invest In Right Now. In this article, we are going to take a look at where Canopy Growth Corporation (NASDAQ:CGC) stands against other best CBD stocks to invest in right now. An essential component of medical marijuana, CBD is the legal, non-psychoactive compound that […] Canopy USA Announces Appointment of Mr. M. Brooks Jorgensen as President Canopy USA, LLC ("Canopy USA"), a brand-driven organization strategically positioned across the fastest growing states and highest potential segments of the U.S. cannabis market, is pleased to announce that effective today, January 6, 2025, Mr. M. Brooks Jorgensen ("Brooks") has been appointed as the Company's first-ever President. Canopy Growth (CGC): One of the Best Pot Stocks to Invest in According to Analysts We recently compiled a list of the 10 Best Pot Stocks To Invest In According to Analysts. In this article, we are going to take a look at where Canopy Growth Corporation (NASDAQ:CGC) stands against other pot stocks to buy according to analysts. The global marijuana market is growing and the market for legal cannabis […] Is Canopy Growth Corporation (CGC) the Best Marijuana Stock to Buy According to Hedge Funds? We recently compiled a list of the 10 Best Marijuana Stocks To Buy According to Hedge Funds. In this article, we are going to take a look at where Canopy Growth Corporation (NASDAQ:CGC) stands against the other marijuana stocks. The United States of America is the country that consumes the most weed in the world. As […] Why Canopy Growth (CGC) Is Among the Best Cannabis Stocks To Invest In? We recently compiled a list of the 11 Best Cannabis Stocks To Invest In. In this article, we are going to take a look at where Canopy Growth Corporation (NASDAQ:CGC) stands against the other best cannabis stocks to invest in. The history of cannabis cultivation in America dates back to the early colonists, who grew […] STORZ & BICKEL Makes History as First Vaporizer Brand to Sponsor NYLON House During Miami Art Week STORZ & BICKEL GmbH ("STORZ & BICKEL"), a world-leading manufacturer of high-end and medically certified vaporizers and a subsidiary of Canopy Growth Corporation ("Canopy Growth") (TSX: WEED) (NASDAQ: CGC), made history during Miami Art Week 2024 as the first vaporizer brand to sponsor NYLON House, hosted by Camila Cabello featuring a live performance from Ludacris and a DJ set by Hugel. Simultaneously, the brand's latest device—the VENTY—won vaporizer of the year at the EMJAYS International Can Canopy Growth and Acreage Confirm Canopy USA's Completed Acquisition of Acreage Canopy Growth Corporation ("Canopy Growth") (TSX: WEED) (NASDAQ: CGC) and Acreage Holdings, Inc. ("Acreage") (CSE: ACRG.A.U, ACRG.B.U) (OTCQX: ACRHF, ACRDF) today confirmed that Canopy USA, LLC ("Canopy USA") has completed its acquisition (the "Acreage Acquisition") of Acreage. Canopy USA now owns 100% of the issued and outstanding shares of Acreage. Canopy Growth's Seasonal Essentials for Gifting, Gathering, and Unwinding Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, announced today the launch of two holiday-inspired cannabis products from Tweed, including a sugar-free Cranberry Ginger Ale and Tweed Snowtorious 91K flower, to bring a little extra cheer to the season's festivities. Canopy Growth and Acreage Provide Update on Closing Timeline Canopy Growth Corporation ("Canopy Growth") (TSX: WEED) (NASDAQ: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, and Acreage Holdings, Inc. ("Acreage") (CSE: ACRG.A.U, ACRG.B.U)(OTCQX: ACRHF, ACRDF), a vertically integrated, multi-state operator of cannabis cultivation and retailing facilities in the U.S., are pleased to announce that it is anticipated that Canopy USA, LLC ("Canopy USA") will complete its acquisition of Acreage on or around Canopy Growth Announces Mr. Luc Mongeau As The Company's Next CEO Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED), (NASDAQ: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, announced today that the Company's board of directors (the "Board") has named current Board member and CPG-veteran, Mr. Luc Mongeau, as the next Chief Executive Officer ("CEO") of Canopy Growth effective January 6, 2025. Canopy Growth Launches Claybourne Infused Pre-Rolls in Canada Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, announced today through an exclusive licensing agreement the launch of the award-winning California grown Claybourne brand in Canada. This initial launch brings Claybourne's Frosted Flyers Infused Pre-Rolls to Canadian medical and adult-use consumers in five distinct offerings, Blue Dream, Strawberry Cough, Pineap Weekly Roundup on the Cannabis Sector & Psychedelic Sector 11-11-2024 Key Takeaways; Cannabis Sector Agrify announced $20 million financing and leadership changes in partnership with Green Thumb Industries TerrAscend reported revenue drop and expanded into Ohio with $10.3 million dispensary acquisition Curaleaf reported $44 million loss in Q3, despite securing a $40 million credit line to support growth Canopy Growth reported revenue drop and continued […] Canopy Growth Corp (CGC) Q2 2025 Earnings Call Highlights: Navigating Revenue Challenges and ... Despite a dip in consolidated net revenue, Canopy Growth Corp (CGC) shows resilience with significant growth in international markets and strategic cost reductions. Canopy Growth Reports Second Quarter Fiscal Year 2025 Financial Results Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC) today announces its financial results for the second quarter ended September 30, 2024 ("Q2 FY2025"). All financial information in this press release is reported in Canadian dollars, unless otherwise indicated. Cannabis stocks fall: FL voters reject legalizing recreational use Cannabis stocks, like Curaleaf (CURLF), Trulieve (TCNNF), Canopy (CGC), Tilray (TLRY), and Cronos (CRON), have fallen after Florida voters rejected a measure to legalize recreational marijuana. Market Domination Hosts Julie Hyman and Josh Lipton examine what the market moves mean. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Naomi Buchanan. Cannabis stocks fall as Florida marijuana legalization fails A ballot measure to legalize recreational marijuana failed in the state of Florida, driving a big blow to the cannabis industry. Shares of Canopy Growth Corporation (CGC) are down 20%, while Tilray Brands (TLRY) drop by over 10% at the time of this video's posting. This comes as Florida was widely seen as a lucrative market for cannabis companies. But while more than half of voters supported legalization for adults aged 21 and older, the measure failed to pass the 60% threshold needed to get into Florida’s constitution.The pathway ahead for cannabis growth in Florida remains uncertain. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here. This post was written by Cindy Mizaku. Election 2024: Harris, Trump agree on cannabis policy The US presidential election is on the horizon. While Vice President Harris and former President Donald Trump differ on many issues, they share common ground on cannabis reform. Poseidon co-founder Emily Paxhia joins Market Domination Overtime to analyze this development. "I think it's finally showing how the electorate's will to see cannabis as a legal resource in the United States is finally reaching the lawmakers and at the highest level of the executive branch in this instance," she explains. Despite this political alignment, cannabis stocks have shown little movement. Paxhia attributes this to "a structural issue around being able to trade in the US" due to custody limitations. She suggests banking reform could resolve this barrier, potentially increasing investor access to cannabis stocks. For more insights on bipartisan support for cannabis reform and regulation, watch the full interview above. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here. This post was written by Angel Smith Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-28-2024 Key Takeaways; Cannabis Sector Chicago Atlantic REIT secured a $50 million loan to fund new marijuana investments Canopy Growth reduced loan term by $100 million to strengthen financial position RIV Capital reported doubling revenue, and strong synergy gains ahead of Cansortium merger Key Takeaways; Psychedelic Sector Awakn expanded phase 3 trial sites for alcohol use […] Canopy Growth to Report Second Quarter Fiscal 2025 Financial Results on November 8, 2024 Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) will release its financial results for the second quarter fiscal year 2025 ended September 30, 2024 before financial markets open on November 8, 2024. Performance Overview Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index Return 11L.MU S&P/TSX Composite index YTD -12.01% +0.63% 1-Year -43.41% +18.14% 3-Year -96.77% +17.50%